NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project

Jessica L. Petrick(National Cancer Institute), Katherine A. McGlynn(National Cancer Institute), Lynn Rosenberg(Boston University), Lifang Hou(Northwestern University), Jean Wactawski‐Wende(University at Buffalo, State University of New York), Mark P. Purdue(Government of the United States of America), Catherine Schairer(National Cancer Institute), Vikrant V. Sahasrabuddhe(Vanderbilt University), Alice J. Sigurdson(National Cancer Institute), I‐Min Lee(Brigham and Women's Hospital), Martha S. Linet(National Institutes of Health), Charles S. Fuchs(University of Southern California), Eric J. Jacobs(American Cancer Society), Peter T. Campbell(Mount Sinai Hospital), Barry I. Graubard(National Cancer Institute), Anne Zeleniuch‐Jacquotte(New York University), Andrew T. Chan(Harvard University), Jill Koshiol(National Cancer Institute), Laura E. Beane Freeman(National Cancer Institute), Neal D. Freedman(National Institutes of Health), Julie E. Buring(Brigham and Women's Hospital), Julie R. Palmer(Boston University), Jie Chen(University of Alberta), Dawn Q. Chong(National Cancer Centre Singapore), John Michael Gaziano(Brigham and Women's Hospital), Albert R. Hollenbeck(AARP), Edward Giovannucci(Harvard University), Howard D. Sesso(Brigham and Women's Hospital), Michael C.R. Alavanja(Division of Cancer Epidemiology and Genetics), Lindsay Y. King(Brigham and Women's Hospital)
Cancer Prevention Research
September 21, 2015
Cited by 94


Related Papers